![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Multicenter, Open-Labeled, Observational Clinical Trial to Investigate the Efficacy and Safety of Oral Administration of Megace Suspension in Patients with Head and Neck Cancer During Radiotherapy |
Korean J Head Neck Oncol. 2008;24(1):57-63. Published online May 30, 2008 |
Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous? 387Evaluation of the efficacy and safety of GM-CSF in the prophylaxis of oral mucositis in patients with head & neck cancer treated with radiotherapy Preventive effect and safety of Chinese herbal medicine for oral mucositis during radiotherapy in patients with head and neck cancer: Study protocol for a randomized trial Oral monilia study on patients with head and neck cancer during radiotherapy CHITOSAN IN THE TREATMENT OF RADIOTHERAPY INDUCED ORAL MUCOSITIS IN HEAD AND NECK CANCER PATIENTS: A RANDOMISD CLINICAL TRIAL Prospective observational study to build the body weight change model during modern concurrent chemo-radiotherapy in head and neck cancer patients 73 Oral Change in haemoglobin levels during radiotherapy for head and neck cancer 38 oral 7 fractions in 7 days versus 7 fractions in 5 daysan interim report on early treatment tolerance in CAIR-2 randomized clinical trial for head and neck cancer patients 351 Oral Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: preliminary results of a multicenter phase III study 843 Poster Analysis of the safety of cumulative dosing of amifostine in a randomized phase III trial of radiation in patients with head and neck cancer |